U1 Bio, Inc. reported raising $450,000 in an initial SEC Form D filing, from an offering of $650,000
Amount Raised
$450,000
Round Type
Seed
San FranciscoBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as U1 Bio, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Dianthus Therapeutics, Inc. raised $8K (Seed) on April 29, 2021.
- Pharmazz raised $250K on April 29, 2021.
- Bilayer Therapeutics, Inc. raised $2M (Seed) on April 29, 2021.
- Cross Vascular, Inc. raised $3.5M (Seed) on April 29, 2021.
- Microsure raised $2.9M (Seed) on April 29, 2021.
- Insight Molecular Diagnostics Inc. raised $3M (Seed) on April 29, 2021.
Who to call at U1 Bio, Inc., and when
A new round usually means U1 Bio, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day U1 Bio, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at U1 Bio, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at U1 Bio, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment U1 Bio, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
U1 Bio, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.